RXRX gains 5.5% in a month on positive pipeline update; long-term hold advised given strong potential of its AI-driven drug discovery platform.

Recursion Pharmaceuticals (RXRX) recently experienced a share price increase of 14% over the last month. This upward movement comes amid a flat broader market trend in the last week and coincides with ...